Harmeet K Kharoud1, Tetyana Mettler2, Martin L Freeman3, Guru Trikudanathan3, Gregory J Beilman4, Srinath Chinnakotla5, Elissa Downs6, Sarah J Schwarzenberg6, Melena D Bellin7. 1. Department of Epidemiology, School of Public Health, Departments of University of Minnesota Medical School, Minneapolis, MN, USA. 2. Pathology, University of Minnesota Medical School, Minneapolis, MN, USA. 3. Medicine, University of Minnesota Medical School, Minneapolis, MN, USA. 4. Surgery, University of Minnesota Medical School, Minneapolis, MN, USA. 5. Surgery, University of Minnesota Medical School, Minneapolis, MN, USA; Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA. 6. Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA. 7. Surgery, University of Minnesota Medical School, Minneapolis, MN, USA; Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA. Electronic address: bell0130@umn.edu.
Abstract
BACKGROUND/ OBJECTIVES: Pancreatogenic diabetes mellitus has been assumed to result from non-immune beta cell destruction when the pancreas is replaced by fibrotic tissue secondary to acute and chronic pancreatitis. We hypothesize that recurrent episodes of pancreatic inflammation may increase the risk for developing β-cell autoimmunity in susceptible individuals. METHODS: We describe 11 patients who had both recurrent acute and/or chronic pancreatitis and type 1 diabetes (T1D) requiring insulin therapy. RESULTS: All 11 patients had positive autoantibodies and 8 patients tested had minimal to undetectable (7/8) or moderate (1/8) stimulated C-peptide at 12 months after T1D onset. Three had biopsy confirmation of insulitis. CONCLUSIONS: These cases lend support to the theory that pancreatitis may increase risk for T1D. We postulate that the pro-inflammatory conditions of pancreatitis may increase posttranslational protein modifications of β-cell antigens and neoepitope generation, which are potential initiating events for loss of β-cell self-tolerance.
BACKGROUND/ OBJECTIVES: Pancreatogenic diabetes mellitus has been assumed to result from non-immune beta cell destruction when the pancreas is replaced by fibrotic tissue secondary to acute and chronic pancreatitis. We hypothesize that recurrent episodes of pancreatic inflammation may increase the risk for developing β-cell autoimmunity in susceptible individuals. METHODS: We describe 11 patients who had both recurrent acute and/or chronic pancreatitis and type 1 diabetes (T1D) requiring insulin therapy. RESULTS: All 11 patients had positive autoantibodies and 8 patients tested had minimal to undetectable (7/8) or moderate (1/8) stimulated C-peptide at 12 months after T1D onset. Three had biopsy confirmation of insulitis. CONCLUSIONS: These cases lend support to the theory that pancreatitis may increase risk for T1D. We postulate that the pro-inflammatory conditions of pancreatitis may increase posttranslational protein modifications of β-cell antigens and neoepitope generation, which are potential initiating events for loss of β-cell self-tolerance.
Authors: Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari Journal: Lancet Gastroenterol Hepatol Date: 2016-10-12
Authors: Melena D Bellin; Mark Lowe; M Bridget Zimmerman; Michael Wilschanski; Steven Werlin; David M Troendle; Uzma Shah; Sarah J Schwarzenberg; John F Pohl; Emily Perito; Chee Yee Ooi; Jaimie D Nathan; Veronique D Morinville; Brian A McFerron; Maria R Mascarenhas; Asim Maqbool; Quin Liu; Tom K Lin; Sohail Z Husain; Ryan Himes; Melvin B Heyman; Tanja Gonska; Matthew J Giefer; Cheryl E Gariepy; Steven D Freedman; Douglas S Fishman; Bradley Barth; Maisam Abu-El-Haija; Aliye Uc Journal: J Pediatr Gastroenterol Nutr Date: 2019-11 Impact factor: 2.839
Authors: John W McGinty; I-Ting Chow; Carla Greenbaum; Jared Odegard; William W Kwok; Eddie A James Journal: Diabetes Date: 2014-04-04 Impact factor: 9.461
Authors: Anna Casu; Paul J Grippo; Clive Wasserfall; Zhaoli Sun; Peter S Linsley; Jessica A Hamerman; Brian T Fife; Adam Lacy-Hulbert; Frederico G S Toledo; Phil A Hart; Georgios I Papachristou; Melena D Bellin; Dhiraj Yadav; Maren R Laughlin; Mark O Goodarzi; Cate Speake Journal: Pancreas Date: 2022-07-01 Impact factor: 3.243